A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain

Paulina D. Ramirez Garcia, Jeffri S. Retamal, Priyank Shenoy, Wendy Imlach, Matthew Sykes, Nghia Truong, Luis Constandil, Teresa Pelissier, Cameron J. Nowell, Song Y. Khor, Louis M. Layani, Chris Lumb, Daniel P. Poole, TinaMarie Lieu, Gregory D. Stewart, Quynh N. Mai, Dane D. Jensen, Rocco Latorre, Nicole N. Scheff, Brian L. Schmidt & 5 others John F. Quinn, Michael R. Whittaker, Nicholas A. Veldhuis, Thomas P. Davis, Nigel W. Bunnett

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Nanoparticle-mediated drug delivery is especially useful for targets within endosomes because of the endosomal transport mechanisms of many nanomedicines within cells. Here, we report the design of a pH-responsive, soft polymeric nanoparticle for the targeting of acidified endosomes to precisely inhibit endosomal signalling events leading to chronic pain. In chronic pain, the substance P (SP) neurokinin 1 receptor (NK1R) redistributes from the plasma membrane to acidified endosomes, where it signals to maintain pain. Therefore, the NK1R in endosomes provides an important target for pain relief. The pH-responsive nanoparticles enter cells by clathrin- and dynamin-dependent endocytosis and accumulate in NK1R-containing endosomes. Following intrathecal injection into rodents, the nanoparticles, containing the FDA-approved NK1R antagonist aprepitant, inhibit SP-induced activation of spinal neurons and thus prevent pain transmission. Treatment with the nanoparticles leads to complete and persistent relief from nociceptive, inflammatory and neuropathic nociception and offers a much-needed non-opioid treatment option for chronic pain.

Original languageEnglish
Number of pages10
JournalNature Nanotechnology
DOIs
Publication statusAccepted/In press - 4 Nov 2019

Keywords

  • biotechnology
  • nanoparticles

Cite this

Ramirez Garcia, Paulina D. ; Retamal, Jeffri S. ; Shenoy, Priyank ; Imlach, Wendy ; Sykes, Matthew ; Truong, Nghia ; Constandil, Luis ; Pelissier, Teresa ; Nowell, Cameron J. ; Khor, Song Y. ; Layani, Louis M. ; Lumb, Chris ; Poole, Daniel P. ; Lieu, TinaMarie ; Stewart, Gregory D. ; Mai, Quynh N. ; Jensen, Dane D. ; Latorre, Rocco ; Scheff, Nicole N. ; Schmidt, Brian L. ; Quinn, John F. ; Whittaker, Michael R. ; Veldhuis, Nicholas A. ; Davis, Thomas P. ; Bunnett, Nigel W. / A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain. In: Nature Nanotechnology. 2019.
@article{f4fa4fe1f0c94e3a8ce70ab0ac12988e,
title = "A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain",
abstract = "Nanoparticle-mediated drug delivery is especially useful for targets within endosomes because of the endosomal transport mechanisms of many nanomedicines within cells. Here, we report the design of a pH-responsive, soft polymeric nanoparticle for the targeting of acidified endosomes to precisely inhibit endosomal signalling events leading to chronic pain. In chronic pain, the substance P (SP) neurokinin 1 receptor (NK1R) redistributes from the plasma membrane to acidified endosomes, where it signals to maintain pain. Therefore, the NK1R in endosomes provides an important target for pain relief. The pH-responsive nanoparticles enter cells by clathrin- and dynamin-dependent endocytosis and accumulate in NK1R-containing endosomes. Following intrathecal injection into rodents, the nanoparticles, containing the FDA-approved NK1R antagonist aprepitant, inhibit SP-induced activation of spinal neurons and thus prevent pain transmission. Treatment with the nanoparticles leads to complete and persistent relief from nociceptive, inflammatory and neuropathic nociception and offers a much-needed non-opioid treatment option for chronic pain.",
keywords = "biotechnology, nanoparticles",
author = "{Ramirez Garcia}, {Paulina D.} and Retamal, {Jeffri S.} and Priyank Shenoy and Wendy Imlach and Matthew Sykes and Nghia Truong and Luis Constandil and Teresa Pelissier and Nowell, {Cameron J.} and Khor, {Song Y.} and Layani, {Louis M.} and Chris Lumb and Poole, {Daniel P.} and TinaMarie Lieu and Stewart, {Gregory D.} and Mai, {Quynh N.} and Jensen, {Dane D.} and Rocco Latorre and Scheff, {Nicole N.} and Schmidt, {Brian L.} and Quinn, {John F.} and Whittaker, {Michael R.} and Veldhuis, {Nicholas A.} and Davis, {Thomas P.} and Bunnett, {Nigel W.}",
year = "2019",
month = "11",
day = "4",
doi = "10.1038/s41565-019-0568-x",
language = "English",
journal = "Nature Nanotechnology",
issn = "1748-3387",
publisher = "Nature Publishing Group",

}

A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain. / Ramirez Garcia, Paulina D.; Retamal, Jeffri S.; Shenoy, Priyank; Imlach, Wendy; Sykes, Matthew; Truong, Nghia; Constandil, Luis; Pelissier, Teresa; Nowell, Cameron J.; Khor, Song Y.; Layani, Louis M.; Lumb, Chris; Poole, Daniel P.; Lieu, TinaMarie; Stewart, Gregory D.; Mai, Quynh N.; Jensen, Dane D.; Latorre, Rocco; Scheff, Nicole N.; Schmidt, Brian L.; Quinn, John F.; Whittaker, Michael R.; Veldhuis, Nicholas A.; Davis, Thomas P.; Bunnett, Nigel W.

In: Nature Nanotechnology, 04.11.2019.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain

AU - Ramirez Garcia, Paulina D.

AU - Retamal, Jeffri S.

AU - Shenoy, Priyank

AU - Imlach, Wendy

AU - Sykes, Matthew

AU - Truong, Nghia

AU - Constandil, Luis

AU - Pelissier, Teresa

AU - Nowell, Cameron J.

AU - Khor, Song Y.

AU - Layani, Louis M.

AU - Lumb, Chris

AU - Poole, Daniel P.

AU - Lieu, TinaMarie

AU - Stewart, Gregory D.

AU - Mai, Quynh N.

AU - Jensen, Dane D.

AU - Latorre, Rocco

AU - Scheff, Nicole N.

AU - Schmidt, Brian L.

AU - Quinn, John F.

AU - Whittaker, Michael R.

AU - Veldhuis, Nicholas A.

AU - Davis, Thomas P.

AU - Bunnett, Nigel W.

PY - 2019/11/4

Y1 - 2019/11/4

N2 - Nanoparticle-mediated drug delivery is especially useful for targets within endosomes because of the endosomal transport mechanisms of many nanomedicines within cells. Here, we report the design of a pH-responsive, soft polymeric nanoparticle for the targeting of acidified endosomes to precisely inhibit endosomal signalling events leading to chronic pain. In chronic pain, the substance P (SP) neurokinin 1 receptor (NK1R) redistributes from the plasma membrane to acidified endosomes, where it signals to maintain pain. Therefore, the NK1R in endosomes provides an important target for pain relief. The pH-responsive nanoparticles enter cells by clathrin- and dynamin-dependent endocytosis and accumulate in NK1R-containing endosomes. Following intrathecal injection into rodents, the nanoparticles, containing the FDA-approved NK1R antagonist aprepitant, inhibit SP-induced activation of spinal neurons and thus prevent pain transmission. Treatment with the nanoparticles leads to complete and persistent relief from nociceptive, inflammatory and neuropathic nociception and offers a much-needed non-opioid treatment option for chronic pain.

AB - Nanoparticle-mediated drug delivery is especially useful for targets within endosomes because of the endosomal transport mechanisms of many nanomedicines within cells. Here, we report the design of a pH-responsive, soft polymeric nanoparticle for the targeting of acidified endosomes to precisely inhibit endosomal signalling events leading to chronic pain. In chronic pain, the substance P (SP) neurokinin 1 receptor (NK1R) redistributes from the plasma membrane to acidified endosomes, where it signals to maintain pain. Therefore, the NK1R in endosomes provides an important target for pain relief. The pH-responsive nanoparticles enter cells by clathrin- and dynamin-dependent endocytosis and accumulate in NK1R-containing endosomes. Following intrathecal injection into rodents, the nanoparticles, containing the FDA-approved NK1R antagonist aprepitant, inhibit SP-induced activation of spinal neurons and thus prevent pain transmission. Treatment with the nanoparticles leads to complete and persistent relief from nociceptive, inflammatory and neuropathic nociception and offers a much-needed non-opioid treatment option for chronic pain.

KW - biotechnology

KW - nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=85074752061&partnerID=8YFLogxK

U2 - 10.1038/s41565-019-0568-x

DO - 10.1038/s41565-019-0568-x

M3 - Article

JO - Nature Nanotechnology

JF - Nature Nanotechnology

SN - 1748-3387

ER -